Likewise, establishing how CP1/CTSL facilitates ASP invasion, characterizing the signal released by MMP2 to laterally inhibit tip cell fate, and determining how proteolytic enzymes cooperate during ASP development might provide new insights regarding ECM remodeling in human cancer progression. The gene discussed is MMP2; the disease is cancer.